- Research works
- 26 ▲ 1995% vs 2013–17
- Citations
- 197 7.7 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 50% world 28%
Not ranked overall: Katsumata Hospital is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Katsumata Hospital?
By fractional works in all years, weighted toward what it does more of than the world: Insulin Resistance, Epidemiology, Cardiovascular Disease, Inflammation, Oxidative Stress, Diabetes, Hypertension and Metabolism.
- ß-Alanine Supplementation
- Clinical Pharmacy
- Neuroprotection
- Prognosis
- Obstructive Sleep Apnea
- Obesity
- Metabolism
- Diabetes
- Oxidative Stress
- Insulin Resistance
- Epidemiology
- Inflammation
- Cardiovascular Disease
- Hypertension
- Aging
- Public Health
- Sleep-Disordered Breathing
- Chemotherapy
- Carnosine
- Pharmaceutical Care
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 20 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 20 words, with their numbers
- Epidemiology4▲ 3.8×16 topics
- Insulin Resistance4▲ 32×5 topics
- Inflammation3▲ 5.0×9 topics
- Oxidative Stress3▲ 5.9×6 topics
- Cardiovascular Disease3▲ 9.1×7 topics
- Diabetes2▲ 18×6 topics
- Hypertension2▲ 25×5 topics
- Metabolism2▲ 13×5 topics
- Aging2▲ 15×4 topics
- Obesity2▲ 9.9×4 topics
- Public Health2▲ 4.8×5 topics
- Obstructive Sleep Apnea2▲ 162×1 topic
- Sleep-Disordered Breathing2▲ 162×1 topic
- Prognosis1▲ 16×4 topics
- Chemotherapy1▲ 6.4×6 topics
- Neuroprotection1▲ 11×2 topics
- Carnosine1▲ 109×1 topic
- Clinical Pharmacy1▲ 253×1 topic
- Pharmaceutical Care1▲ 253×1 topic
- ß-Alanine Supplementation1▲ 109×1 topic
Which research topics does Katsumata Hospital publish most on?
By volume in 2022–2025: Interprofessional Education and Collaboration, Infection Control in Healthcare, Antibiotic Use and Resistance and Nosocomial Infections in ICU.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Interprofessional Education and Collaboration General Health Professions 0 works
- 2 Infection Control in Healthcare Infectious Diseases 0 works
- 3 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 0 works
- 4 Nosocomial Infections in ICU Critical Care and Intensive Care Medicine 0 works
- 5 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 0 works
- 6 Aortic Disease and Treatment Approaches Pulmonary and Respiratory Medicine 0 works
- 7 Cardiac Valve Diseases and Treatments Cardiology and Cardiovascular Medicine 0 works
- 8 Chronic Disease Management Strategies Epidemiology 0 works
- 9 Pharmacy and Medical Practices Pharmacology 0 works
- 10 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Katsumata Hospital's research output changed?
Output in 2018–2022 was 1995% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Nagoya
- Nagoya University
- Nagoya Institute of Technology
- Nagoya City University
- Meijo University
- Aichi Cancer Center
- Toyota Technological Institute
- Aichi Gakuin University
- Nagoya University Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.